Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious, and other diseases.


Analyst Coverage

Cowen and CompanyRitu Baral
EVA DimensionsCasey Lea
Janney Montgomery Scott LLCDr Debjit Chattopadhyay
Jefferies LLCGena Wang, PhD, CFA
JMP SecuritiesLiisa Bayko
Leerink Partners LLCJoseph P. Schwartz
Needham & CompanyChad Messer, PhD
Oppenheimer & Company Michelle Gilson
Piper Jaffray & Co.Edward A. Tenthoff
RBC Capital MarketsDr Simos Simeonidis Phd
Robert W. Baird & Co.Brian Skorney, CFA
Roth Capital PartnersJeff Martin
SunTrust Robinson HumphreyEdward H. Nash
WBB Securities, LLCStephen G. Brozak
WedbushHeather Behanna
William BlairTim Lugo
Sarepta Therapeutics Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Sarepta Therapeutics Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Sarepta Therapeutics Inc. or its management. Sarepta Therapeutics Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.